vs
Assertio Holdings, Inc.（ASRT）与JOINT Corp（JYNT）财务数据对比。点击上方公司名可切换其他公司
JOINT Corp的季度营收约是Assertio Holdings, Inc.的1.1倍（$15.2M vs $13.5M），JOINT Corp同比增速更快（3.1% vs -57.9%），过去两年JOINT Corp的营收复合增速更高（-28.6% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
JOINT Corp是美国领先的脊椎按摩护理诊所运营方与特许经营商，主打高性价比的脊椎护理服务，推出会员制护理方案，面向寻求非侵入式肌肉骨骼疼痛管理及日常健康调理的消费者。
ASRT vs JYNT — 直观对比
营收规模更大
JYNT
是对方的1.1倍
$13.5M
营收增速更快
JYNT
高出61.0%
-57.9%
两年增速更快
JYNT
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $15.2M |
| 净利润 | — | $991.1K |
| 毛利率 | — | 81.4% |
| 营业利润率 | -86.7% | 4.9% |
| 净利率 | — | 6.5% |
| 营收同比 | -57.9% | 3.1% |
| 净利润同比 | — | 5510.5% |
| 每股收益（稀释后） | $-4.54 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTJYNT
| Q4 25 | $13.5M | $15.2M | ||
| Q3 25 | $49.5M | $13.4M | ||
| Q2 25 | $29.2M | $13.3M | ||
| Q1 25 | $26.5M | $13.1M | ||
| Q4 24 | $32.2M | $14.7M | ||
| Q3 24 | $29.2M | $30.2M | ||
| Q2 24 | $31.1M | $30.3M | ||
| Q1 24 | $32.4M | $29.7M |
净利润ASRTJYNT
| Q4 25 | — | $991.1K | ||
| Q3 25 | $11.4M | $855.0K | ||
| Q2 25 | $-16.4M | $93.4K | ||
| Q1 25 | $-13.5M | $967.8K | ||
| Q4 24 | — | $17.7K | ||
| Q3 24 | $-2.9M | $-3.2M | ||
| Q2 24 | $-3.7M | $-3.6M | ||
| Q1 24 | $-4.5M | $947.0K |
毛利率ASRTJYNT
| Q4 25 | — | 81.4% | ||
| Q3 25 | — | 80.1% | ||
| Q2 25 | — | 79.1% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 90.7% | ||
| Q2 24 | — | 90.7% | ||
| Q1 24 | — | 90.9% |
营业利润率ASRTJYNT
| Q4 25 | -86.7% | 4.9% | ||
| Q3 25 | 23.2% | 1.2% | ||
| Q2 25 | -27.5% | -8.6% | ||
| Q1 25 | -50.0% | -5.2% | ||
| Q4 24 | -41.9% | 5.5% | ||
| Q3 24 | -10.4% | -1.6% | ||
| Q2 24 | -11.6% | -5.9% | ||
| Q1 24 | -13.4% | -1.4% |
净利率ASRTJYNT
| Q4 25 | — | 6.5% | ||
| Q3 25 | 23.1% | 6.4% | ||
| Q2 25 | -56.0% | 0.7% | ||
| Q1 25 | -51.1% | 7.4% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | -10.0% | -10.5% | ||
| Q2 24 | -11.8% | -11.9% | ||
| Q1 24 | -13.9% | 3.2% |
每股收益（稀释后）ASRTJYNT
| Q4 25 | $-4.54 | $0.06 | ||
| Q3 25 | $0.11 | $0.06 | ||
| Q2 25 | $-0.17 | $0.01 | ||
| Q1 25 | $-0.14 | $0.06 | ||
| Q4 24 | $-3.28 | $0.01 | ||
| Q3 24 | $-0.03 | $-0.21 | ||
| Q2 24 | $-0.04 | $-0.24 | ||
| Q1 24 | $-0.05 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $23.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $15.1M |
| 总资产 | $267.0M | $61.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTJYNT
| Q4 25 | $63.4M | $23.6M | ||
| Q3 25 | $93.4M | $29.7M | ||
| Q2 25 | $98.2M | $29.8M | ||
| Q1 25 | $87.3M | $21.9M | ||
| Q4 24 | $100.1M | $25.1M | ||
| Q3 24 | $88.6M | $20.7M | ||
| Q2 24 | $88.4M | $17.5M | ||
| Q1 24 | $80.7M | $18.7M |
总债务ASRTJYNT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTJYNT
| Q4 25 | $94.0M | $15.1M | ||
| Q3 25 | $105.8M | $22.7M | ||
| Q2 25 | $93.3M | $23.2M | ||
| Q1 25 | $108.5M | $22.8M | ||
| Q4 24 | $121.1M | $20.7M | ||
| Q3 24 | $130.5M | $20.5M | ||
| Q2 24 | $132.2M | $23.2M | ||
| Q1 24 | $134.5M | $26.2M |
总资产ASRTJYNT
| Q4 25 | $267.0M | $61.0M | ||
| Q3 25 | $319.8M | $69.4M | ||
| Q2 25 | $273.8M | $73.2M | ||
| Q1 25 | $286.4M | $80.1M | ||
| Q4 24 | $284.7M | $83.2M | ||
| Q3 24 | $276.0M | $79.6M | ||
| Q2 24 | $279.4M | $82.4M | ||
| Q1 24 | $282.0M | $85.7M |
负债/权益比ASRTJYNT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | — | $334.7K |
| 自由现金流率自由现金流/营收 | — | 2.2% |
| 资本支出强度资本支出/营收 | — | 9.9% |
| 现金转化率经营现金流/净利润 | — | 1.86× |
| 过去12个月自由现金流最近4个季度 | — | $-1.9M |
8季度趋势，按日历期对齐
经营现金流ASRTJYNT
| Q4 25 | $-30.0M | $1.8M | ||
| Q3 25 | $-4.8M | $1.8M | ||
| Q2 25 | $19.1M | $868.6K | ||
| Q1 25 | $-12.5M | $-3.7M | ||
| Q4 24 | $11.5M | $9.4M | ||
| Q3 24 | $-35.0K | $3.4M | ||
| Q2 24 | $7.4M | $-973.5K | ||
| Q1 24 | $7.5M | $2.8M |
自由现金流ASRTJYNT
| Q4 25 | — | $334.7K | ||
| Q3 25 | — | $1.5M | ||
| Q2 25 | — | $363.6K | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $8.2M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $2.4M |
自由现金流率ASRTJYNT
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 10.9% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | -30.8% | ||
| Q4 24 | — | 55.9% | ||
| Q3 24 | — | 10.6% | ||
| Q2 24 | — | -4.1% | ||
| Q1 24 | — | 8.1% |
资本支出强度ASRTJYNT
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.3% |
现金转化率ASRTJYNT
| Q4 25 | — | 1.86× | ||
| Q3 25 | -0.42× | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
